API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211404
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213506
https://www.prnewswire.com/news-releases/new-report-supports-use-of-caldolor-as-a-standard-of-care-across-patient-populations-302106304.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218359
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217236
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-24-2024-24602.pdf
https://www.globenewswire.com/news-release/2023/10/18/2762028/0/en/Hyloris-announces-U-S-FDA-Approval-of-Maxigesic-IV.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217261
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216999
https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/now-you-will-need-a-prescription-for-buying-aspirin-ibrufin-diclofinac-in-delhi-read-why/articleshow/102003935.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216994
https://www.prnewswire.com/news-releases/caldolor-now-fda-approved-for-treatment-of-fever--pain-in-infants-301823848.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-10-2023-12326.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217514
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213565
https://www.pharmacompass.com/pdf/news/spi-pharma-inc-announces-signing-of-regional-sole-distribution-agreement-for-actillets-mcc-microcrystalline-cellulose-pellets-tap-tartaric-acid-pellets-and-directly-compressible-ibuprofen-dc100-with-ingredientpharm-84886.pdf
https://endpts.com/fda-revises-action-on-compounded-ibuprofen-citing-oral-version-shortage/
https://www.accessdata.fda.gov/scripts/ires/index.cfm?action=print.getPrintData&ts=11202310416
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/nppa-revises-ceiling-prices-of-128-formulations/articleshow/97033906.cms
https://www.yicaiglobal.com/news/china-ibuprofen-paracetamol-output-jumps-five-fold-to-190-million-pills-a-day-minister-says#:~:text=(Yicai%20Global)%20Dec.,for%20industry%20and%20information%20technology.
https://health.economictimes.indiatimes.com/news/pharma/chinese-cry-for-paracetamol-as-govt-pushes-for-traditional-drug-lianhua-qingwen/96496791
https://mp.weixin.qq.com/s?__biz=MzI1ODI3MjMwMQ==&mid=2247489159&idx=1&sn=0bbbcee026d84fc70553d4c7d5d1e21c&chksm=ea0bebc5dd7c62d37ec539662b8b4b6322c117236df3b710258495cb3ed527bd5ea7cf680f97&token=428904583&lang=zh_CN#rd
https://www.dsij.in/dsijarticledetail/this-pharma-company-gets-approval-to-set-up-a-new-manufacturing-facility-for-its-popular-drug-ibuprofen-27086-1
https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-recordati-rare-diseases-pedea-5-mg-slash-ml-solution-for-injection-el-22-a-slash-45
https://www.business-standard.com/article/companies/largest-ibuprofen-api-maker-eyes-double-revenue-in-next-four-years-122090801140_1.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214071
https://www.business-standard.com/article/news-cm/strides-pharma-gets-usfda-approval-for-ibuprofen-oral-suspension-122053000174_1.html
https://investor.cumberlandpharma.com/news-releases/news-release-details/caldolorr-now-fda-approved-pre-operative-administration
https://www.sciencedaily.com/releases/2021/11/211109120349.htm#:~:text=11%2F211109120349.htm-,New%20research%20suggests%20there%20may%20someday%20be%20a%20role%20for,wintertime%20infection%20for%20the%20elderly.
https://www.globenewswire.com/news-release/2021/11/01/2324058/0/en/Hyloris-Announces-FDA-Acceptance-of-New-Drug-Application-for-Maxigesic-IV-in-Post-Operative-Pain.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214699
https://www.gov.uk/government/news/combined-paracetamol-and-ibuprofen-medicine-approved-for-general-sale
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211890
https://www.business-standard.com/article/economy-policy/nppa-allows-50-price-hike-for-ibuprofen-ranitidine-carbamazepine-121070300071_1.html
https://www.business-standard.com/article/economy-policy/nppa-allows-50-price-hike-for-ibuprofen-ranitidine-carbamazepine-121070300071_1.html
https://www.forbes.com/sites/forbesfellows/2021/06/18/new-report-suggests-biosimliar-drugs-push-biologic-treatment-prices-lower/
https://www.accesswire.com/651001/Lexaria-Provides-Progress-Report-on-Six-RD-Programs
https://www.newswire.ca/news-releases/labelling-update-regarding-the-use-of-non-steroidal-anti-inflammatory-drugs-nsaids-beyond-20-weeks-of-pregnancy-and-risk-of-kidney-damage-to-unborn-babies-866562162.html
https://ecipharma.com/2021/04/23/eci-pharmaceuticals-llc-enters-into-exclusive-u-s-distribution-agreement-for-ibuprofen/
https://ecipharma.com/2021/04/23/eci-pharmaceuticals-llc-enters-into-exclusive-u-s-distribution-agreement-for-ibuprofen/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211666
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214003
https://www.prnewswire.com/news-releases/caldolor-demonstrates-significant-reduction-of-opioid-use-in-orthopedic-trauma-patients-301095788.html
https://www.reuters.com/article/us-health-coronavirus-britain-ibuprofen/uk-doctors-to-trial-ibuprofen-in-covid-19-patients-with-breathing-difficulties-idUSKBN23A1DV?feedType=RSS&feedName=healthNews
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213794
https://www.manufacturingchemist.com/news/article_page/Ibuprofen_and_COVID-19_to_use_or_not_to_use/164570
https://www.gov.uk/government/news/commission-on-human-medicines-advice-on-ibuprofen-and-coronavirus-covid-19